Arcturus Therapeutics Holdings Inc. Gains 21.06%
Thu, Dec 16, 2021 at 05:30 PM
Arcturus Therapeutics Holdings Inc. (ARCT:NASDAQ) jumped higher at $43, a gain of 21.1%. On Wed, Dec 15, 2021, ARCT:NASDAQ hit a New 2-Week Intraday Low of $33.21. The stock got featured on our News Catalysts scanner on Thu, Dec 16, 2021 at 08:52 AM in the 'BIOTECH' category. From Wed, Dec 01, 2021, the stock recorded 50.00% Up Days and 45.45% Green Days
The stock spiked on Tue, Aug 10, 2021 at $65 with a volume of 658M+, and its share price has been moving sideways in recent weeks.
About Arcturus Therapeutics Holdings Inc. (ARCT:NASDAQ)
Arcturus Therapeutics Ltd is a biotechnology company developing novel RNA medicines. The company develops novel RNA medicines in therapeutic areas including infectious disease, cystic fibrosis, nonalcoholic steatohepatitis (NASH) and rare liver diseases.
Top 10 Gainers:
- ADGI (ADGI:NASDAQ), 123.31%
- XFIN (XFIN:NASDAQ), 100%
- Kaixin Auto Holdings (KXIN:NASDAQ), 36.29%
- Assertio Therapeutics, Inc. (ASRT:NASDAQ), 23.7%
- Aptose Biosciences Inc. (APTO:NASDAQ), 23.53%
- CALT (CALT:NASDAQ), 22.29%
- Arcturus Therapeutics Holdings Inc. (ARCT:NASDAQ), 21.06%
- Zai Lab Limited (ZLAB:NASDAQ), 20.69%
- BSN (BSN:NYSE), 19.06%
- X4 Pharmaceuticals, Inc. (XFOR:NASDAQ), 17.33%